Profile
PTIX VRTX REGN VRNA ARGX ALNY
Company Name Protagenic Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.12M $116.75B $76.56B $72.68B $52.08B $51.68B
Employees 0.00K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Garo H. Armen Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
PTIX VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
PTIX VRTX REGN VRNA ARGX ALNY
Last Close $2.07 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $11.1 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.2 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -81.35 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 935 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
PTIX VRTX REGN VRNA ARGX ALNY
1 Month Return -35.71 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -25.54 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -31.68 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 675.28 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 322.45 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 256.34 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PTIX VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.47 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - 9.76 % 4.25 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.06 % - - -
Growth
PTIX VRTX REGN VRNA ARGX ALNY
Asset Growth -54.76 % 14.15 % 53.91 %
Gross Profit Growth -78.21 % 12.5 % -
Revenue Growth - 8.27 % -
Revenue 3 Year - -13.44 % -15.89 %
Revenue 5 Year - 119.18 % -
Revenue 10 Year - 429.43 % -
EBIT Growth -22.05 % 13.17 % -131.37 %
Net Income Growth -10.5 % 11.61 % -224.78 %
Net Income 3 Yeari Growth Per Share 8.14 % -46.47 % -148.34 %
Net Income 5 Yeari Growth Per Share -65.17 % 111.07 % 25.82 %
Net Income 10 Yeari Growth Per Share 72.05 % 1232.49 % -35.51 %
Operating Income Growth -25.93 % -8.23 % -133.02 %
Operating Cash Flow Growth (CFG) -13.84 % -3.78 % -143.33 %
Operating 3 Year CFG -13.31 % -38.85 % -170.73 %
Operating 5 Year CFG -352.31 % 84.11 % 54.81 %
Operating 10 Year CFG 73.14 % 517.51 % 40.15 %
EPS Growth 1.74 % 10.39 % -214.81 %
EPS Diluted Growth 1.74 % 10.27 % -208.93 %
Book Value Per Share -75.51 % 11.76 % -22.82 %
Share Holder 3 Year Equity Growth Per Share -92.34 % 53.21 % 1.82 %
Share Holder 5 Year Equity Growth Per Share 183.6 % 167.88 % -24.45 %
Share Holder 10 Year Equity Growth Per Share 104.91 % 1113.59 % -71.86 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth - 0.06 % 139.05 %
Free Cash Flow Growth -9.42 % -0.08 % -144.48 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
PTIX VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 300 % 86.28 % 85.39 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -415.97 % 14.78 % 11.4 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 336.39 % 19.62 % 15.31 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM 86.64 % 19.59 % 10.32 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 88.98 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 136.21 % 111.4 % 139.5 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM 26048.11 % 34.06 % 25.89 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -144.16 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.51 1.93 1.91 3.33
Payables Turnover TTM 0.03 0.4 2.3 2.37 0.9 4.37
Inventory Turnover TTM 46.78 0.99 0.64 0.94 2.26 6.82
Fixed Asset Turnover TTM -48.91 % 388.59 % 284.82 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM -1.17 % 47.15 % 35.47 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -2.46 14.55 48.94 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -2.46 13.06 40.09 -0.85 5.58 1.68
Cash Per Share TTM 147.21 % 2459.7 % 8148.65 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM 18095.37 % 31.71 % 35.59 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.92 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -144.16 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.69 34.99 18.43 -995.27 133.11 233.46
Price To Operating Cash Flows Ratio TTM -0.66 31.28 15.15 -126.33 152.03 193.4
Price Cash Flow Ratio TTM -0.66 31.28 15.15 -126.33 152.03 193.4
Income Statement (TTM)
PTIX VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.2B $0.03B $2.19B $2.25B
Gross Profit $-0B $9.49B $12.23B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 86.13% 93.89% 89.62% 85.62%
EBITDA $-0.01B $0.49B $5.32B $-0.12B $0.11B $-0.18B
Net Income $-0.01B $-0.54B $4.41B $-0.14B $0.83B $-0.28B
EPS Diluted -1.13 -2.08 38.34 -1.73 12.78 -2.18
Balance Sheet (MRQ)
PTIX VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.7B $0.12B $0.03B $2.59B
Total Liabilities $0B $6.12B $8.41B $0.27B $0.7B $4.17B
Total Equity $0B $16.41B $29.35B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.7B $0.12B $0.04B $2.74B
Total Assets $0B $22.53B $37.76B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
PTIX VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.41B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0B $-0.49B $4.42B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.76B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 28.72
AARD Aardvark Therapeutics, Inc. Common Stock 13.2075
ABCL AbCellera Biologics Inc. 3.345
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.84
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.05
ABPWW 0.014
ABSI Absci Corporation 3.365
ABUS Arbutus Biopharma Corporation 4.63
ABVC ABVC BioPharma, Inc. 2.045
ABVX Abivax SA American Depositary Shares 110.69
ACAD ACADIA Pharmaceuticals Inc. 26.93
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4808
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.235
ACIU AC Immune SA 2.93
ETFs With Exposure to PTIX
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 209.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 160.26
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 160.27
VEMPX Vanguard Extended Market Index InstlPlus 0 395.49
Unlock